UnknownNot Applicable

Percutaneous Transhepatic Intrahepatic Portosystemic Shunt for Treatment of Portal Vein Occlusion With Symptomatic Portal Hypertension After Splenectomy

China50 participantsStarted 2010-10

Plain-language summary

To evaluate the values of percutaneous transhepatic intrahepatic portosystemic shunt for treatment of portal vein occlusion with symptomatic portal hypertension after splenectomy.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * All patients with portal hypertension who have the history of splenectomy and have enough image information to confirm occlusion of portal vein Exclusion Criteria: * Patients with known severe dysfunction of heart, lung, brain, kidney and other vital organs

What they're measuring

No gastrointestinal rebleeding in 1 month after interventions

Timeframe: 1 month

Ascites disappear in 1 month after interventions

Timeframe: 1 month

Trial details

NCT IDNCT02505152

SponsorSun Yat-sen University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2016-12

Contact for this trial

Zaibo Jiang, MD.

+86 020 85252066 jiangzaibo@aliyun.com

View on ClinicalTrials.gov More Hypertension, Portal trials